TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/24 16:05 | 3/4/24 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Adawi Kamal | CA | O | CFO,Corp | S | -24 | 1.91 | 0 | -13 | -5 | 244 | D | ||||||||||||||
2/8/24 16:05 | 2/6/24 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Adawi Kamal | CA | O | CFO,Corp | S | -13 | 1.95 | 0 | -7 | -4 | 182 | D | ||||||||||||||
3/3/23 16:38 | 3/2/23 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Adawi Kamal | CA | O | CFO,Corp | S | -8 | 2.30 | 0 | -4 | -2 | 188 | D | ||||||||||||||
2/10/23 16:05 | 2/8/23 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Adawi Kamal | CA | O | CFO,Corp | S | -16 | 2.69 | 0 | -6 | -6 | 92 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |